
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Fructo-Oligosaccharide
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : CEN Biotech
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Fructo-Oligosaccharide is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
January 12, 2024
Lead Product(s) : Fructo-Oligosaccharide
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : CEN Biotech
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Non Digestible Carbohydrates
Therapeutic Area : Endocrinology
Study Phase : Undisclosed
Sponsor : BioFortis
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Non Digestible Carbohydrates is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Prediabetic State.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
February 23, 2021
Lead Product(s) : Non Digestible Carbohydrates
Therapeutic Area : Endocrinology
Highest Development Status : Undisclosed
Sponsor : BioFortis
Deal Size : Inapplicable
Deal Type : Inapplicable
